Prevalance Rate:

Amyloidosis: Rare Disease

Amyloidosis is listed as a "rare disease" by the Office of
Rare Diseases (ORD) of the National Institutes of Health
(NIH). This means that Amyloidosis, or a subtype of Amyloidosis,
affects less than 200,000 people in the US population.

Ophanet, who are a consortium of European partners,
currently defines a condition rare when if affects 1 person per 2,000.
They list Amyloidosis as a "rare disease".
More information about Amyloidosis is available from Orphanet

Prevelance statistics for Amyloidosis:

The following statistics relate to the prevalence of Amyloidosis:

60 to 65% of cases of amyloidosis occurs in men in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)

Only 1% of amyloidosis patients are under 40 in the US (Amyloidosis: Recognition, Prognosis and Conventional Therapy, American Society of Hematology)

More Statistics about Amyloidosis:

About prevalence and incidence statistics:

The term 'prevalence' of Amyloidosis usually refers to the estimated population
of people who are managing Amyloidosis at any given time.
The term 'incidence' of Amyloidosis refers to the annual diagnosis rate,
or the number of new cases of Amyloidosis diagnosed each year.
Hence, these two statistics types can differ:
a short-lived disease like flu can have high annual incidence but low prevalence,
but a life-long disease like diabetes has a low annual incidence but high prevalence.
For more information see about prevalence and incidence statistics.

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.